M Mazumdar, JR Glassman - Statistics in medicine, 2000 - Wiley Online Library
Categorizing prognostic variables is essential for their use in clinical decision‐making. Often a single cutpoint that stratifies patients into high‐risk and low‐risk categories is sought …
CH Weaver, B Hazelton, R Birch, P Palmer, C Allen… - 1995 - ashpublications.org
The CD34 antigen is expressed by committed and uncommitted hematopoietic progenitor cells and is increasingly used to assess stem cell content of peripheral blood progenitor cell …
W Bensinger, F Appelbaum, S Rowley… - Journal of Clinical …, 1995 - ascopubs.org
PURPOSE To analyze factors that affect the collection of peripheral-blood stem cells (PBSC) before transplant and the tempo of engraftment after transplant. PATIENTS AND METHODS …
R Haas, R Mohle, S Fruhauf, H Goldschmidt, B Witt… - 1994 - ashpublications.org
For patients with advanced-stage or poor-prognosis malignant lymphoma, high-dose therapy with peripheral blood progenitor cell (PBPC) support may become a first-line …
WI Bensinger, K Longin, F Appelbaum… - British journal of …, 1994 - Wiley Online Library
Factors affecting mobilization and engraftment were analysed in 54 patients undergoing transplant using autologous PBSCs mobilized with high‐dose recombinant granulocyte …
JE Frampton, CR Lee, D Faulds - Drugs, 1994 - Springer
Synopsis Filgrastim, a recombinant human granulocyte colony-stimulating factor (G-CSF), has identical biological activity to that of endogenous human G-CSF, but differs in that it …
U Narayanasami, R Kanteti, J Morelli… - Blood, The Journal …, 2001 - ashpublications.org
Peripheral blood cell (PBC) rescue has become the mainstay for autologous transplantation in patients with lymphoma, multiple myeloma, and solid tumors. Different methods of …
O Hartmann, AGL Corroller, D Blaise… - Annals of internal …, 1997 - acpjournals.org
Background: Previous studies have suggested that peripheral blood stem cell (PBC) transplantation has an advantage over autologous bone marrow transplantation. Objective …
EJ Shpall, R Champlin, JA Glaspy - Biology of Blood and Marrow …, 1998 - tctjournal.org
The CD34+ cell surface antigen is expressed on progenitor cells required for blood stem cell transplantation. The number of cells expressing CD34+ can be used to assess the …